• No results found

Cover Page The handle

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/61076 holds various files of this Leiden University dissertation.

Author: Reiding, K.R.

Title: High-throughput mass spectrometric N-glycomics

Issue Date: 2018-04-05

(2)

High-throughput mass spectrometric N-glycomics

Karli Robert Reiding

(3)

ISBN: 978-94-6295-891-3

© Karli Reiding. All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means without permission of the author or the journals holding the copyrights of the published manuscripts. All published material was reprinted with permission.

The work presented in this thesis was performed at the Center for Proteomics and Metabolomics, Leiden University Medical Center, The Netherlands.

The work was supported by the European Union Seventh Framework Programme HighGlycan project, grant number: 278535.

Cover and chapter design: Boudien Reiding & Karli Reiding Printing: ProefschriftMaken || www.proefschriftmaken.nl

(4)

High-throughput mass spectrometric N-glycomics

Proefschrift ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof.mr. C.J.J.M. Stolker,

volgens besluit van het College voor Promoties te verdedigen op donderdag 5 april 2018

klokke 10.00 uur door Karli Robert Reiding geboren te Rotterdam

in 1985

(5)

Promotores: Prof.dr. M. Wuhrer Prof.dr. A.M. Deelder Leden promotiecommissie: Prof.dr. C.H. Hokke

Prof.dr. P.E. Slagboom

Dr. R. Fahey (NIBRT Glycoscience Group, National Institute for Bioprocessing Research and Training, Dublin, Ireland) Dr. D.J. Lefeber (Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands;

Translational Metabolic Laboratory, Radboud University Medical Center, Nijmegen, The Netherlands)

(6)

Table of contents

Chapter 1 – General introduction ... 9

1.1 Glycosylation ... 11

1.2 Monosaccharide structure ... 12

1.3 The biosynthesis of protein N-glycosylation ... 14

1.4 Glycosylation in health and disease ... 16

1.5 Glycan analysis ... 18

1.6 Matrix-assisted laser desorption/ionization mass spectrometry ... 19

1.7 Chemical derivatization for MALDI-MS glycan analysis ... 21

1.8 Scope ... 23

1.9 References ... 24

Chapter 2 – High-throughput analysis and automation for glycomics studies ... 31

2.1 Abstract ... 32

2.2 Introduction ... 33

2.3 High-throughput sample preparation ... 35

2.4 Use of internal standards ... 40

2.5 Integration of analysis workflows ... 42

2.6 Automation of sample preparation... 43

2.7 Data analysis ... 45

2.8 Conclusion ... 46

2.9 Acknowledgments ... 49

2.10 References ... 49

(7)

Chapter 3 – High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS

employing linkage-specific sialic acid esterification ... 55

3.1 Abstract ... 56

3.2 Introduction ... 57

3.3 Experimental section ... 58

3.4 Results ... 63

3.5 Discussion ... 71

3.6 Supporting information ... 72

3.7 Acknowledgments ... 73

3.8 References ... 73

Chapter 4 – Automation of high-throughput mass spectrometry-based plasma N-glycome analysis with linkage-specific sialic acid esterification ... 77

4.1 Abstract ... 78

4.2 Introduction ... 79

4.3 Experimental section ... 80

4.4 Results and discussion ... 84

4.5 Conclusion ... 87

4.6 Supporting information ... 87

4.7 Acknowledgments ... 88

4.8 References ... 88

Chapter 5 – Murine plasma N-glycosylation traits associated with sex and strain ... 91

5.1 Abstract ... 92

5.2 Introduction ... 93

5.3 Experimental section ... 94

5.4 Results ... 97

5.5 Discussion ... 103

5.6 Conclusions and perspectives ... 106

5.7 Acknowledgments ... 107

5.8 References ... 107

(8)

Chapter 6 – Human plasma N-glycosylation as analyzed by MALDI-FTICR-MS associates

with markers of inflammation and metabolic health ... 111

6.1 Abstract ... 112

6.2 Introduction ... 113

6.3 Experimental procedures ... 114

6.4 Results ... 119

6.5 Discussion ... 128

6.6 Supporting information ... 132

6.7 Acknowledgments ... 132

6.8 References ... 132

Chapter 7 – Serum protein N-glycosylation changes with rheumatoid arthritis disease activity during and after pregnancy ... 139

7.1 Abstract ... 140

7.2 Introduction ... 141

7.3 Methods ... 142

7.4 Results ... 144

7.5 Discussion ... 149

7.6 Summary ... 151

7.7 Acknowledgments ... 151

7.8 Additional information ... 151

7.9 References ... 151

Chapter 8 – High-throughput serum N-glycomics: method comparison and application to study rheumatoid arthritis and pregnancy-associated changes ... 155

8.1 Abstract ... 156

8.2 Introduction ... 157

8.3 Results ... 158

8.4 Discussion ... 166

8.5 Summary ... 169

8.6 Methods ... 170

8.7 References ... 172

(9)

Chapter 9 – General discussion ... 177

9.1 Developments in linkage-specific sialic acid esterification ... 179

9.2 Persistent challenges in mass spectrometric N-glycomics ... 181

9.3 Developments human plasma N-glycosylation analysis ... 185

9.4 Future prospects of plasma N-glycosylation analysis by MALDI-MS ... 190

9.5 Concluding remarks ... 192

9.6 References ... 193

English summary ... 203

Nederlandse samenvatting ... 207

Acknowledgements ... 211

Curriculum Vitae ... 212

Publications and submitted manuscripts ... 213

Referenties

GERELATEERDE DOCUMENTEN

CHAPTER 2 A HILIC-BASED HIGH-THROUGHPUT SAMPLE PREPARATION METHOD FOR N-GLYCAN ANALYSIS FROM TOTAL HUMAN PLASMA. GLYCOPROTEINS

Changes in glycosylation pattern have been recorded with increasing calendar age and for several disease states, and reviewing them all here would be too exten-

While the obtained 2-AA-labeled N- glycan samples of both carbon and HILIC SPE were of comparable quality as jud- ged by MALDI-TOF-MS and by HILIC HPLC with fluorescence

Among the tested HILIC stationary phases, Biogel P-10 was chosen as it resulted in a CGE-LIF total plasma N-glycome profile which was very similar to the profile obtained after

Next, alterations in total plasma N-glycosylation that mark familial longevity are identified and the role of lipid profiles is investigated, given the previously

Decreased levels of bisecting GlcNAc in the context of non-galactosylated glycans of IgG1 and IgG2 were associated with familial longevity in younger participants

In this Chapter, it was shown that a strategy consisting of large-scale immuno-affinity capturing of proteins from human plasma using a bead-based method, coupled with

Another aspect of total plasma N-glycan profiling is that glycans from the high- abundant proteins dominate the glycan profiles, and therefore only changes in the